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Abstract
We studied the association between OTC pharmaceutical sales and volume of patients with influenza-like-illnesses (ILI) at an
urgent care center over one year. OTC pharmaceutical sales explain 36% of the variance in the patient volume, and each
standard deviation increase is associated with 4.7 more patient visits to the urgent care center (p,0.0001). Cross-correlation
function analysis demonstrated that OTC pharmaceutical sales are significantly associated with patient volume during non-
flu season (p,0.0001), but only the sales of cough and cold (p,0.0001) and thermometer (p,0.0001) categories were
significant during flu season with a lag of two and one days, respectively. Our study is the first study to demonstrate and
measure the relationship between OTC pharmaceutical sales and urgent care center patient volume, and presents strong
evidence that OTC sales predict urgent care center patient volume year round.
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Introduction
Surveillance and response to diseases are key priorities for the
Centers for Disease Control and Prevention (CDC) and the U.S.
public health system. [1] Syndromic surveillance is the real-time
monitoring of health-related data for early detection of potential
outbreaks before traditional, diagnosis-based surveillance by
health departments. [2–4] Although initially developed to detect
large-scale bioterrorism events, syndromic surveillance has the
potential to rapidly and sensitively detect infectious disease
outbreaks, enabling earlier response to minimize adverse impact.
[5] Prior to confirmed medical diagnosis, behavioral patterns and
non-clinical data of ailing patients may be analyzed and modeled
from a variety of data sources [6].
One source of data for syndromic surveillance is over-the-
counter (OTC) pharmaceutical sales. [7–8] OTC pharmaceuticals
are purchased without a prescription and include cough syrup, flu
remedies, or pediatric oral rehydration solutions. OTC sales have
been correlated with infectious disease outbreaks. [9–12] Patients
with influenza-like-illness (ILI) or upper respiratory tract infection
(URI) are more likely to purchase OTC pharmaceuticals than
present to their personal physician or an emergency department
(ED). [9,13] Furthermore, elevation in OTC pharmaceutical sales
has been shown to precede elevation in ED or hospital patient
volume by one to seventeen days. [10–12] Although these previous
studies demonstrate that OTC sales correlate with ED and
hospital patient volume for ILI and URI, most people with mild
ILI or URI do not present initially to an ED or hospital. [14]
These may be non-ideal settings to accurately track patient
behavior and the underlying disease trends in a population, which
is the goal of syndromic surveillance. Thus, these studies may have
underestimated the power of OTC sales as a source of data for
syndromic surveillance.
Urgent care centers provide walk-in ambulatory medical service
for acute illness and injuries not serious enough to require the full
resources of a hospital ED. [15] They are rapidly growing across
the U.S. Since most cases at urgent care centers are related to
respiratory illness, [16] correlating OTC sales to ILI patient
volume at urgent care centers may more accurately illustrate the
sensitivity of OTC sales as a syndromic monitoring method. In this
analysis we examined the association between OTC sales and ILI
patient volume at an urgent care center to determine the feasibility
and functionality of OTC sales to monitor endemic ILI.
Materials and Methods
IRB approval was obtained, and the authors have no conflicts of
interests for this study.
Measurement of OTC Pharmaceutical Sales
The National Retail Data Monitor (NRDM) is a public health
surveillance tool that collects information on OTC health care
products sold in over 29,000 stores across the country (rod-
s.health.pitt.edu/NRDM.htm). The NRDM has been active since
2002. Sales data is updated electronically and stratified by zip
codes, product sale category and promotion status. This system
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was pioneered by the Real-time Outbreak and Disease Surveil-
lance Laboratory (RODS) at the Department of Biomedical
Informatics at the University of Pittsburgh. [17–18] After approval
from the Pennsylvania Department of Health, we used NRDM to
tabulate daily quantities of OTC pharmaceuticals sold in thirteen
zip codes comprising the greater Pittsburgh area from July 1, 2010
through July 31, 2011. Six out of eighteen sales categories from the
NRDM system were selected for their relevance to ILI (Table 1).
Each sales category was exclusive except for cough and cold,
which is the sum of all sales of cold relief and cough products as
well as additional uncategorized products. A previous study has
demonstrated that the separation of products being on sale or sold
at a discount does not affect the ability of the NRDM to
distinguish disease activity in the community [18].
Urgent Care Overview
The UPMC Urgent Care at Shadyside (UPMC Urgent Care) is
located in an urban neighborhood (zip code 15232) outside of
Pittsburgh. It is owned and operated by UPMC, a large academic
hospital system affiliated with the University of Pittsburgh School
of Medicine. The UPMC Urgent Care opened in January 2010
with operating hours from 9 a.m. to 9 p.m. seven days per week. A
physician is always present and is supported by additional mid-
level providers as dictated by patient volume. The center employs
between 3–5 nurses and ancillary staff. Most patients present to
the UPMC Urgent Care for upper respiratory infection, flu-like
symptoms, or minor trauma and lacerations. The UPMC Urgent
Care utilizes an electronic medical record (EMR) from Epic (www.
epic.com, Verona, Wisconsin) which is linked to the UPMC
outpatient medical record system.
Measurement of the Volume of Patients with ILI at the
Urgent Care Center
Several methods have been used to detect an outbreak of ILI,
including influenza surveillance data, manual review of hospital
charts, and ICD-9 codes. [5] ICD-9 codes from the ED or
hospitals have been used as the gold standard of patient volume in
previous syndromic surveillance studies using OTC pharmaceu-
tical sales. [10–12] For this study, daily patient volume of ILI at
the UPMC Urgent Care was accessed from the Epic EMR system.
Patients were selected on the basis of a set of 18 ICD-9 codes
(Table 2) based on clinical knowledge and previous validations of
similar code sets. [19–20] All data was de-identified and could not
be linked back to any protected health information. This study was
approved by the University of Pittsburgh Institutional Review
Board as an exempt study.
Statistical Analysis
Rather than use raw daily data, we decided a priori to use a 7-
day moving-average (7dMA) for OTC sales and patient volume to
minimize the day-of-the-week effect. [21–22] This is accomplished
by averaging the variable over 3 days prior and 3 days after the
day of interest. This dampens the day-of-the-week effect on OTC
pharmaceutical sales and patient volume (i.e., reduces noise) while
minimizing assumptions about data structure and other temporal
trends.
In this analysis we examined the association of OTC sales
(predictor) to urgent care ILI patient volume (outcome) using two
analytic methods: 1) ordinary least squares regression (OLS); 2)
autoregressive integrated moving average (ARIMA) modeling.
OLS regression was used to determine the simple association of
OTC sales to patient volume without taking into account the
temporal nature of the data. This allows us to answer the
questions: a) Is patient volume high when OTC sales are high? b)
How many more patients present to urgent care with ILI, on
average, with a standard increase in OTC sales? The shape of the
association of OTC sales with patient volume was explored with
lowess smoothed curves. Lowess curves suggested that over the
Table 1. Selected OTC Pharmaceutical Categories from the
National Retail Data Monitor.
Categories Used in analysis
Antidiarrheal Not Selected
Antifever Pediatric Selected
Antifever Adult Selected
Bronchial Remedies Not Selected
Chest Rubs Not Selected
Cold Relief Adult Liquid Not Selected
Cold Relief Adult Tablet Not Selected
Cold Relief Pediatric Liquid Not Selected
Cold Relief Pediatric Tablet Not Selected
Cough Syrup Adult Liquid Not Selected
Cough Adult Tablet Not Selected
Cough Syrup Pediatric Liquid Not Selected
Cough and Cold Selected
Electrolytes Pediatric Selected
Hydrocortisones Not Selected
Nasal Product Internal Not Selected
Thermometers Selected
Throat Lozenges Selected
OTC, over-the-counter.
doi:10.1371/journal.pone.0059273.t001
Table 2. ICD-9 Code Set for the Selection of Patients with
Influenza-Like-Illnesses.
Syndromes ICD-9 Codes
Pharyngitis 462, 463, 034.0
URI 465.8, 465.9
Laryngitis 464.00, 464.4
Sinusitis 461, 461.9
Cough 786.2
Viral Syndrome 079.99
Pneumonia 486*
Otitis Media 382.9
Conjunctivitis 372
Bronchitis 490, 466
Flu 487.8, 487.1
*The documentation and coding system used at the Urgent Care system only
included 486 as the diagnosis for all clinical pneumonia, as only clinical and
radiographic evidence was available. No specific definitive testing was
performed at the Urgent Care, and the only available ICD-9 code available for
the provider to select at the time of disposition was 486 by default for any
patient that qualified clinically for pneumonia.
doi:10.1371/journal.pone.0059273.t002
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majority of the data a linear trend was appropriate. Subsequently,
OLS regression was used to determine the magnitude of the
association of OTC sales with the volume of patients with ILI. We
present the amount of variance in the volume of patients with ILI
accounted for by OTC pharmaceutical sales with the each model’s
overall r2. Model regression coefficients illustrate the average
increase in number of patients presenting to urgent care with ILI
given a standard deviation increase in OTC sales. This association
was determined for the entire time period (July 1, 2010–July 31,
2011) and for pre-flu season (July 1, 2010–Nov 30, 2010), flu
season (Dec 1, 2010–March 31, 2011), and post-flu season (April 1,
2011–July 31, 2011) to determine if OTC sales track with patient
volume differently depending on the time of the year.
Next, we used ARIMA modeling to take into account the
temporal nature of the data. ARIMA models calculate the
correlation between two fluctuating signals, such as OTC sales
and patient volume. Correlation is denoted by a cross correlation
function (CCF). CCFs range from 0 (no correlation between
signals) to 1 (perfect correlation between signals). CCFs are
calculated for data on the same day and by shifting the signals in 1-
day increments, called the lag. This allowed us to determine if
OTC sales are most strongly correlated with patient volume on the
same day, or if changes in OTC sales precedes changes in patient
volume. Again, the association was determined for the entire time
period and for pre-flu season, flu season, and post-flu season to
determine if OTC sales track with patient volume differently
depending on the time of the year.
For both OLS regression and ARIMA modeling we conducted
a sensitivity analysis where we lengthened the flu season by one
month (Dec 1, 2010–April 30, 2011). Trends were consistent with
those from the primary analysis, so only results from the primary
analysis are presented. For the entire analysis a two-sided p-value
,0.05 was used to determine statistical significance. SAS 9.2 (SAS
Institute Inc., Cary, NC) was used for all analysis.
Results
Between July 1st, 2010 and July 31st, 2011, UPMC Urgent Care
was visited by 7,813 patients with at least one of the 18 pre-
selected ICD-9 codes (table 2). Among them, 68% of patients had
only one ICD-9 diagnosis code, 27% had two codes, and 4% had
three or more codes. The majority of the patients (66%) resided
within the thirteen zip codes queried from the NRDM database.
Of the thirteen zip codes requested, two did not have a pharmacy
registered with the NRDM. Patients in those zip codes account for
6% (n= 470) of the sample and were included in the study. The
7dMA of total OTC pharmaceutical sales and ILI patient volume
are shown in Figure 1. The 7dMA of the ILI patient volume
against the sales of cough and cold, chest rubs, and thermometers
are in Figure 2 (A, B, and C).
OLS regression indicated that sales of OTC pharmaceuticals
were significantly and positively associated with ILI patient volume
(Table 3). Over the entire time period, sales of cough and cold
therapies, chest rubs, and thermometers were most strongly
associated with ILI patient volume. Individually, these sales
accounted for 36–39% of the variance in patient volume
(P,0.0001). A SD increase in the sale of these pharmaceuticals
was associated with an average increase of 4.8–4.9 patients
presenting to urgent care with ILI. When the time period was
stratified it was evident that associations between OTC sales and
patient volume were influenced by time of the year. During pre-flu
season, chest rubs, cough and cold therapies, and throat lozenges
explained a large amount of variance in ILI patient volume
(r2 = 0.771 to 0.829, all P,0.0001). Strikingly, during flu season,
only thermometer sales was moderately associated with ILI patient
volume (r2 = 0.485, P,0.0001), followed by cough and cold
therapies (r2 = 0.164, P,0.0001). A SD increase in thermometer
sales during flu season was associated with an average increase of
4.9 patients presenting with ILI to urgent care. In post-flu season,
throat lozenges (r2 = 0.787, P,0.0001), antifever adult medicines
(r2 = 0.708, P,0.0001), cough and cold therapies (r2 = 0.697,
P,0.0001), and chest rubs (r2 = 0.662, P,0.0001) were most
associated with ILI patient volume.
The ARIMA analysis was used to calculate the CCF between
OTC sales and patient volume taking into account the temporality
of the data. Overall, OTC sales and patient volume were
significantly correlated (Table 4). Consistent with results from
the OLS analysis, over the entire time period sales of cough and
cold therapies (CCF=0.621, P,0.05), chest rubs (CCF=0.605,
P,0.05), and thermometers (CCF=0.602, P,0.05) were most
strongly associated with patient volume. Stratification of the time
period again indicated time-dependent associations between OTC
sales and patient volume. In pre-flu season, chest rubs
(CCF=0.911, lag = 0 day, P,0.05), cough and cold therapies
(CCF=0.898, lag = 3 days, P,0.05), and throat lozenges
(CCF=0.878, lag = 0 days, P,0.05) were most strongly correlated
with patient volume. Lags indicate that sale of cough and cold
therapies was most strongly correlated with patient volume 3 days
later, while sale of chest rubs and throat lozenges were most
strongly correlated with patient volume on the same day. Notably,
in pre-flu season, thermometer sales were strongly correlated with
patient volume (CCF=0.698, lag = 8 days, P,0.05), with a lag
indicating that changes in thermometer sales preceded changes in
patient volume by 8 days, a sizable amount.
During flu season thermometers were again most strongly
associated with ILI patient volume (CCF=0.697, lag = 1 day,
P,0.05), with changes in sales preceding changes in patient
volume by 1 day. It is notable though that the CCF for
thermometers was highly stable across lags, indicating that
thermometer sales have essentially equivalent correlation with
ILI patient volume even using thermometer sales 1–7 days before
patient volume. Cough and cold therapies were moderately
correlated with patient volume (CCF=0.412, lag = 2 days,
P,0.05). Sale of chest rubs (CCF=20.517, lag =215 days,
P,0.05) and throat lozenges (CCF=0.568, lag =215 days,
P,0.05) were also moderately correlated with patient volume
though the large negative lag indicates that fluctuations in patient
volume preceded fluctuations in sale of these OTCs.
In post-flu season, throat lozenges, antifever adult medicine,
cough and cold therapies, and chest rubs were most strongly
correlated with patient volume, again consistent with results from
OLS regression. Thermometers were less strongly correlated with
patient volume but remained significant with a moderately high
correlation (CCF=0.696, lag = 0, P,0.05).
Discussion
Syndromic surveillance is an important public health tool for
the early detection and response of disease outbreaks, and its
effectiveness depends on timeliness, sensitivity, and false-alarm
rates. [5] OTC pharmaceutical sales have been used to predict
patient volume using ED visits as a proxy of the underlying disease
outbreak, [10–12] with the assumption that patients self-medicate
with non-prescription products before presenting at the ED. [23]
No studies have examined such relationship in an urgent care
setting. This study found that there is strong association between
changes in OTC pharmaceutical sales with patient visits for ILI
Pharmaceutical Sales for ILI in the Urgent Care
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symptoms at an academic-affiliated urgent care in an urban setting
of Pittsburgh.
Results from our OLS regression and ARIMA models support
the hypothesis that OTC sales are highly correlated with ILI
patient volume at urgent care. Moreover, they suggest which
OTCs are most correlated with patient volume at specific time
points. The general trend between various OTC sales and ILI
patient volume is that most OTC categories peaked before the flu
season but thermometers peaked during the flu season (Figure 1
and 2). Specifically, during pre-flu and post-flu seasons, cough and
cold therapies, chest rubs, and throat lozenges are most strongly
associated with patient volume. During flu season, only sale of
thermometers appeared strongly associated with ILI patient
volume and the CCF was highly stable 1–7 days before patient
volume. The purchasing behavior of consumers probably depends
on the predominating symptoms, which include allergies or
respiratory difficulties during the non-flu season and fever or
cough during the flu season.
This study found strong independent associations between three
categories of OTC pharmaceuticals collected by NRDM in the
Pittsburgh region with the volume of patients with ILI at the
UPMC Urgent Care at Shadyside. The increase in the sales of
cough and cold, chest rubs, or thermometers explained 38%, 37%,
and 36% of the variance in the volume of patients with ILI at the
UPMC Urgent Care, respectively. For people with ILI symptoms,
cough and cold medication can relieve rhinorrhea, coughing, or
myalgia. Thermometers allow people to determine whether they
have a fever. Even though chest rubs have questionable clinical
evidence for symptom relief, there may be a local preference to
this product in the Pittsburgh region. Of note, the r2 values from
our analysis were lower than the results from previous studies on
day-of-the-week effects (r2 = 0.3620.38 vs. r2 = 0.7520.86). [21–
22] Part of the reason is because patient volume at the urgent care
is known to be highly and independently dependent on day-of-the-
week effects, while OTC pharmaceutical sales are a surrogate of
disease outbreak which is independent of time on a daily scale.
During the flu season, more people purchase OTC pharma-
ceuticals and visit urgent cares as the prevalence of infectious
diseases increases. Even though all NRDM categories were
significantly related to volume of patients with ILI for the whole
year in a regression analysis, we found that only the sales of
thermometers and cough and cold medications were still
significantly associated during the flu season. This is perhaps due
to people purchasing all types of OTC pharmaceuticals and
seeking medical attention at urgent cares for symptoms caused by
non-influenza infections or allergic sources during the non-flu
season. When contracted with influenza during the peak months,
patients are more likely to have elevated temperature and develop
symptoms needing thermometers and cough and cold medica-
tions. Specifically, the much higher variance of ILI patient volume
explained by the thermometer sales over cough and cold sales
(48.5% vs. 16.4%) perhaps is partly caused by the price difference
and the specificity of fever in ILI. Moreover, results from our
cross-correlation analysis indicated that surges in the volume of
patients with ILI at the urgent care lagged behind changes in
cough and cold medications by two days and behind thermom-
eters by one day during the flu season. This suggests that people
seek medical attention at urgent cares promptly after purchasing
these OTC pharmaceuticals, as suggested by previous studies
using patient visits at the ED [10–12].
The association between OTC pharmaceutical sales and
volume of patients with ILI at the urgent care from our findings
allows for another syndromic surveillance tool. Public health
monitoring in an urgent care setting can be applicable for the
surveillance for outbreaks of routine infectious diseases or
uncommon but potentially devastating bioterrorism events.
Infectious diseases accounted for only 2.6% of all ambulatory
care visits and 11.2% of all ED visits, [24] but half of the visits to
urgent cares. [16] Feasibility of urgent care for the detection of a
bioterrorism event was examined at the Salt Lake 2002 Olympic
Winter Games in Utah, where the state’s health departments
collected electronic data from 19 urgent care facilities and found
no unexpected or man-made disease outbreaks. [25] Because
earlier intervention to prevent a bioterrorism event, even by
several days, can potentially save thousands of lives and billions of
dollars, [26] expanding syndromic surveillance at the urgent care
setting could be cost effective and highly clinically relevant. De-
identified urgent care data can be used throughout the whole year
and augmented to include the sales of thermometers and cough
and cold medications during flu season. Information can be
Figure 1. ILI Patient Volume vs. Total OTC Sales (7dMA). Seven day moving average (7dMA) of OTC pharmaceutical sales and volume of
patients with influenza-like-illness (ILI) patient volume at the UPMC Urgent Care from July 1, 2010 to July 31, 2011. Volume of patients with ILI is blue
and on the left y-axis, and OTC pharmaceutical sales is red and on the right y-axis.
doi:10.1371/journal.pone.0059273.g001
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Table 3. Ordinary least square regression analysis of the
association of OTC sales with urgent care ILI patient volume.
Entire time period (July 1, 2010–July 31, 2011)
Category r2 b*
SD (OTC
sales) B6SD** P-value
Cough and Cold 0.385 0.020 245.5 4.9 ,0.0001
Chest Rubs 0.366 0.591 8.1 4.8 ,0.0001
Thermometers 0.363 1.485 3.2 4.8 ,0.0001
Electrolytes Pediatric 0.269 0.952 4.3 4.1 ,0.0001
Throat Lozenges 0.183 0.105 32.1 3.4 ,0.0001
Antifever Adult 0.168 0.136 23.8 3.2 ,0.0001
Antifever Pediatric 0.120 0.568 4.8 2.7 ,0.0001
Total 0.360 0.015 311.1 4.7 ,0.0001
Pre-flu season (July 1, 2010–Nov 30, 2010)
Category r2 b* SD (OTC
sales)
b6SD** P-value
Cough and Cold 0.797 0.014 253.6 3.6 ,0.0001
Chest Rubs 0.829 0.572 6.3 3.6 ,0.0001
Thermometers 0.323 1.314 1.7 2.3 ,0.0001
Electrolytes Pediatric 0.212 0.618 3.0 1.8 ,0.0001
Throat Lozenges 0.771 0.138 25.3 3.5 ,0.0001
Antifever Adult 0.465 0.248 11.0 2.7 ,0.0001
Antifever Pediatric 0.083 0.427 2.7 1.1 0.0003
Total 0.807 0.012 294.9 3.6 ,0.0001
Flu season (Dec 1, 2010–March 31, 2011)
Category r2 b* SD (OTC
sales)
b6SD** P-value
Cough and Cold 0.164 0.032 89.5 2.8 ,0.0001
Chest Rubs 0.003 0.071 5.2 0.4 0.56
Thermometers 0.485 1.540 3.2 4.9 ,0.0001
Electrolytes Pediatric 0.000 0.040 3.1 0.1 0.85
Throat Lozenges 0.009 0.044 14.9 0.7 0.3
Antifever Adult 0.007 20.042 13.7 20.6 0.37
Antifever Pediatric 0.000 0.019 3.8 0.1 0.91
Total 0.114 0.020 115.8 2.3 0.0002
Post-flu season (April 1, 2011–July 31, 2011)
Category r2 b* SD (OTC
sales)
b6SD** P-value
Cough and Cold 0.697 0.022 166.6 3.7 ,0.0001
Chest Rubs 0.662 1.394 2.6 3.6 ,0.0001
Thermometers 0.484 1.942 1.6 3.1 ,0.0001
Electrolytes Pediatric 0.492 1.279 2.4 3.1 ,0.0001
Throat Lozenges 0.787 0.185 21.0 3.9 ,0.0001
Antifever Adult 0.708 0.155 23.8 3.7 ,0.0001
Antifever Pediatric 0.529 1.389 2.3 3.2 ,0.0001
Total 0.723 0.017 216.7 3.7 ,0.0001
ILI, influenza like illness. OTC, over the counter medication. SD, standard deviation.
*b represents the increase in the number of urgent care patients per unit
increase in the sale of OTC medication.
**b represents the increase in the number of urgent care patients per SD
increase in the sale of OTC medication.
doi:10.1371/journal.pone.0059273.t003
Table 4. ARIMA analysis of the association of OTC sales with
urgent care ILI patient volume.
Entire time period (July 1, 2010–July 31, 2011)
Category CCF (SE) Lag* P-value ,0.05**
Cough and Cold 0.621 (0.050) 0 Y
Chest Rubs 0.605 (0.050) 0 Y
Thermometers 0.602 (0.050) 0 Y
Electrolytes Pediatric 0.519 (0.050) 0 Y
Throat Lozenges 0.428 (0.050) 0 Y
Antifever Adult 0.410 (0.050) 0 Y
Antifever Pediatric 0.347 (0.050) 0 Y
Total 0.600 (0.050) 0 Y
Pre-flu season (July 1, 2010–Nov 30, 2010)
Category Maximum CCF (SE) Lag* P-value ,0.05**
Cough and Cold 0.898 (0.081) 3 Y
Chest Rubs 0.911 (0.081) 0 Y
Thermometers 0.698 (0.081) 8 Y
Electrolytes Pediatric 0.547 (0.081) 7 Y
Throat Lozenges 0.878 (0.081) 0 Y
Antifever Adult 0.715 (0.081) 24 Y
Antifever Pediatric 0.481 (0.081) 15 Y
Total 0.901 (0.081) 3 Y
Flu season (Dec 1, 2010–March 31, 2011)
Category Maximum CCF (SE) Lag* P-value ,0.05**
Cough and Cold 0.412 (0.091) 2 Y
Chest Rubs 20.517 (0.091) 215 Y
Thermometers 0.697 (0.091) 1 Y
Electrolytes Pediatric 0.293 (0.091) 9 Y
Throat Lozenges 0.568 (0.091) 215 Y
Antifever Adult 0.135 (0.091) 14 N
Antifever Pediatric 0.323 (0.091) 15 Y
Total 0.342 (0.091) 2 Y
Post-flu season (April 1, 2011–July 31, 2011)
Category Maximum CCF (SE) Lag* P-value ,0.05**
Cough and Cold 0.835 (0.092) 0 Y
Chest Rubs 0.813 (0.092) 0 Y
Thermometers 0.696 (0.092) 0 Y
Electrolytes Pediatric 0.701 (0.092) 0 Y
Throat Lozenges 0.887 (0.092) 0 Y
Antifever Adult 0.841 (0.092) 0 Y
Antifever Pediatric 0.727 (0.092) 1 Y
Total 0.850 (0.092) 0 Y
ARIMA, autoregressive integrated moving average. CCF, cross correlation
function. ILI, influenza like illness. OTC, over the counter medication. SE,
standard error.
*For analysis of the entire time period the lag was fixed to 0. For analysis of sub-
periods the lag was limited to within 15 days. A positive lag indicates sale of
OTC medication is correlated with future urgent care patient volume. A
negative lag indicates sale of OTC medication is correlated with past urgent
care patient volume.
**P-value ,0.05 was determined if: CCF - (1.966SE) .0.
doi:10.1371/journal.pone.0059273.t004
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Figure 2. ILI Patient Volume vs. Cough and Cold, Chest Rub, and Thermometer Sales Volume (7dMA). Seven day moving average
(7dMA) of sales volume of Cough and Cold medications (A), Chest Rubs (B), and Thermometers (C) in comparison with and volume of patients with
influenza-like-illness (ILI) at the UPMC Urgent Care from July 1, 2010 to July 31, 2011. Volume of patients with ILI is blue and on the left y-axis, and the
three different categories of OTC pharmaceutical sales are on the right y-axis.
doi:10.1371/journal.pone.0059273.g002
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channeled electronically to systems such as the National Electronic
Disease Surveillance System and the Public Health Information
Network, which provide Internet-based infrastructure and industry
standards for interoperability and fast communication.
Another potential use of the syndromic surveillance from the
NRDM data is to manage staffing at urgent cares to improve care
delivery and infection control, [22] which observed that 18.5% less
people left without being seen and 30% reduction in patient
complaints when patient volume is predicted using non-clinical
indicators such as day-of-the-week effects. As urgent cares see only
20–50 patients per day, [16] most places are not able to handle
large fluctuations in patient volume. Predictors such as OTC
pharmaceuticals can enhance the preparation of urgent cares to
ensure that patients can receive proper treatment and thus control
the spread of diseases, which is especially crucial during flu
seasons. [27] Furthermore, longer wait times at the urgent cares
may lead to increase in nosocomial infection as their equipment
and personnel often harbor airborne infectious viruses [25].
One limitation of our study is that our data only spanned
thirteen months, i.e. one flu season, and consisted of information
at the Pittsburgh area. Therefore, our finding is more prone to
fluctuations of purchasing pattern, medical attention seeking
behavior, and disease outbreak of that year in the city that we
examined. We suspected that by following the correlation of
various OTC sales with ILI patient volume over multiple years
would increase the power of the study but maintain the general
pattern, as a study that spanned three years that observed OTC
sales with ED patient volume have found [7].
Conclusions
Our study is the first study to demonstrate and measure the
relationship between OTC pharmaceutical sales and urgent care
center patient volume, and presents strong evidence that OTC
sales predict urgent care center patient volume year round. Larger
studies using multiple sites across a longer period of time would
allow for a more accurate analysis of the relationship between
OTC pharmaceutical sales and volume of patients with ILI at the
urgent cares.
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